2006
DOI: 10.1021/jm061123i
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Antifungal Activity, and Structure−Activity Relationships of Coruscanone A Analogues

Abstract: Coruscanone A, a plant derived cyclopentenedione derivative, showed potent in vitro antifungal activity against Candida albicans and Cryptococcus neoformans, comparable to amphotericin B and fluconazole. A series of analogs have been synthesized by modification of the cyclopentenedione ring, the enolic methoxy functionality, and the side chain styryl moiety of this natural product lead. A structurally close 1,4-benzoquinone analog was also prepared. All the compounds were examined for their in vitro activity a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
54
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(54 citation statements)
references
References 33 publications
0
54
0
Order By: Relevance
“…The activity of coruscanone A, which is isolated from the Peruvian pepper plant Piper coruscan, was comparable to or greater than that of amphotericin B. Coruscanone A also has a potent effect on fungal strains that are resistant to fluconazol, and it is therefore considered an alternative for the treatment of high risk immunocompromised patients and may also be of use as template for a new class of synthetic antifungal agents Babu et al, 2006). However, there have been no studies demonstrating an activity of cyclopentenediones against protozoa.…”
Section: Resultsmentioning
confidence: 99%
“…The activity of coruscanone A, which is isolated from the Peruvian pepper plant Piper coruscan, was comparable to or greater than that of amphotericin B. Coruscanone A also has a potent effect on fungal strains that are resistant to fluconazol, and it is therefore considered an alternative for the treatment of high risk immunocompromised patients and may also be of use as template for a new class of synthetic antifungal agents Babu et al, 2006). However, there have been no studies demonstrating an activity of cyclopentenediones against protozoa.…”
Section: Resultsmentioning
confidence: 99%
“…The isolated compounds were evaluated for antimicrobial (Candida albicans ATCC 90028, Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853, Mycobacterium intracellulare ATCC 23068, Aspergillus fumigat ATCC 90906, Methicillin Resistant Staphylococcus aureus ATCC 43300) ( Bharate et al, 2007 ;Babu et al, 2006 ), antileishmanial and antimalarial activity [P. falciparum (D6 clone) and P. falciparum (W2 clone)] ( Bharate et al, 2007 ).…”
Section: Antimicrobial Antileishmanial and Antimalarial Bioassaymentioning
confidence: 99%
“…For example, a number of 2-(1H-imidazol-1-yl)-1-phenylethanone derivatives (for example 16 in Figure 2) exhibit powerful activities against C. albicans and P. chrysogenum, but moderate activity against A. niger at a concentration of 10 µg/mL [20]. In addition, (E)-2-((E)-1-methoxy-3-phenylallylidene)-4-methylcyclopent-4-ene-1,3-dione (17 in Figure 2) exhibited varying degrees of antifungal activity against fungi C. albicans ATCC 90028 (2.08 µg/mL), C. neoformans ATCC 90113 (8.33 µg/mL) and A. fumigatus ATCC 90906 (>20 µg/mL) [21]. Given these facts, it is reasonable to expect that a compound combining these two moieties may have antifungal activities.…”
Section: Introductionmentioning
confidence: 99%